GBT Technologies Inc (GTCH)

[canthelpit]

due dilligence i thought i searched high and low but i might stand corrected and apologize if i was wrong GBT GTCH signed a second letter of intent last august that was swept under the carpet with GTX CORP deal was signed LOI to be compleated by 12/31/22 never heard news if going thru or disolved ,,,, GBT Technologies and GTX Corp Enter into a Second Letter of Intent Covering the Potential Worldwide Licensing rights for the Manufacturing, Sales and Distribution Focusing on qTerm THERE IS A WEB SITE UP AND RUNNING NOW for QTERM with pre order for the wiget that takes the vitals,,,,, licenced under GBT TECHNOLOGIES at the bottom of page site can be accessed here https://qterm.me . patent to be received on may 2 ,,, tuesday ,,,,,,,,,,GTCH
0.00%
GBT Technologies Inc.
April 20, 2023·4 min read
In this article:

GTCH
0.00%
Watchlist

Watchlist
GBT Technologies Inc.
GBT Technologies Inc.
The patent will be granted on May 2, 2023, and protecting AI based sophisticated, electronic health device

SAN DIEGO, April 20, 2023 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) announced that it received a noticed issue and will be granted on May 2, 2023, U.S. patent number 11,638,523, covering its machine learning-driven, human vitals device, non-provisional patent application, qTerm non-provisional patent was filed on August 3, 2020, describing an intelligent, electronic health device to measure human vitals with a touch of a finger, which was assigned qTerm as an internal project name. GBT successfully completed the development of a fully working prototype in 2022 including robust testing, debugging and a participant study. qTerm’s first release measures body temperature, blood oxygen and heart rate vitals. Future releases are planned to include blood pressure measurement and enhanced, AI-driven analytics. The device is accompanied by a smartphone mobile app and synchronized web application to keep measurement history and provide analytics for user's records at a later phase. The web and mobile applications also enable direct access to user’s data anywhere around the world, enabling efficient, remote telemedicine capabilities. Upon user’s permission, a user’s body temperature and location can be anonymously shared with other users to provide health risk proximity alerts. The patent describes advanced AI technology to perform on-going vitals monitoring and analytics, providing personal health related notifications and alerts. GBT plans to file a continuation patent for qTerm, further strengthening the underlying intellectual property concepts. For more information visit qTerm™ | Vital Signs Al Device.